Evidence map›Paper›PMID 24143976›Full record

ArticleMethods in cell biology2013

Bioluminescence resonance energy transfer methods to study G protein-coupled receptor-receptor tyrosine kinase heteroreceptor complexes.

Dasiel O Borroto-Escuela, Marc Flajolet, Luigi F Agnati, Paul Greengard, Kjell Fuxe

Abstract read
In one paragraph

Article in Methods in cell biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 95 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. TrkB receptor interacts with mGluScience advances · 2024
    Article
  9. Review
  10. Ratiometric Detection of ZnChemistry (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. The mGluMolecular neurobiology · 2022
    Article
  15. A BRET CaScience signaling · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Dasiel O Borroto-EscuelaDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Marc Flajolet
Luigi F Agnati
Paul Greengard
Kjell Fuxe
Karolinska Institutet · SERockefeller University · USIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

THE ROLE OF DARPPS IN THE ACUTE AND CHRONIC EFFECTS OF COCAINE AND AMPHETAMINEP01DA010044 · NIDA · ROCKEFELLER UNIVERSITY · PI GREENGARD, PAUL · 1996 to 2015
$23.6M
Striatal Cell-specific Analysis of the Molecular Mechanisms of Antipsychotic DrugP50MH090963 · NIMH · ROCKEFELLER UNIVERSITY · PI FLAJOLET, MARC · 2010 to 2014
$9.8M
NIDA NIH HHS DA10044NIDA NIH HHS P01 DA010044NIMH NIH HHS MH090963NIMH NIH HHS P50 MH090963
6 · The paper itself

Abstract

A large body of evidence indicates that G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs) can form heteroreceptor complexes. In these complexes, the signaling from each interacting protomer is modulated to produce an integrated and therefore novel response upon agonist(s) activation. In the GPCR-RTK heteroreceptor complexes, GPCRs can activate RTK in the absence of added growth factor through the use of RTK signaling molecules. This integrative phenomenon is reciprocal and can place also RTK signaling downstream of GPCR. Formation of either stable or transient complexes by these two important classes of membrane receptors is involved in regulating all aspects of receptor function, from ligand binding to signal transduction, trafficking, desensitization, and downregulation among others. Functional phenomena can be modulated with conformation-specific inhibitors that stabilize defined GPCR states to abrogate both GPCR agonist- and growth factor-stimulated cell responses or by means of small interfering heteroreceptor complex interface peptides. The bioluminescence resonance energy transfer (BRET) technology has emerged as a powerful method to study the structure of heteroreceptor complexes closely associated with the study of receptor-receptor interactions in such complexes. In this chapter, we provide an overview of different BRET(2) assays that can be used to study the structure of GPCR-RTK heteroreceptor complexes and their functions. Various experimental designs for optimization of these experiments are also described.

Indexed as

AdenosineAdenosine A2 Receptor AgonistsBinding, CompetitiveBioluminescence Resonance Energy Transfer TechniquesDose-Response Relationship, DrugFibroblast Growth Factor 2Gene ExpressionGreen Fluorescent ProteinsHEK293 CellsHumansKineticsLuciferases, RenillaPhenethylaminesPlasmidsProtein BindingProtein Multimerization2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosineAdenosineAdenosine A2 Receptor AgonistsFGFR1 protein, humanFibroblast Growth Factor 2Green Fluorescent ProteinsLuciferases, RenillaPhenethylaminesReceptor, Adenosine A2AReceptor, Fibroblast Growth Factor, Type 1Allosteric modulationBioluminescence resonance energy transfer (BRET)BRET competition assaysBRET kinetics and dose–response assaysBRET saturation assaysGPCR–RTK heteroreceptor complexesG protein-coupled receptors (GPCRs)HeterodimerizationHeteroreceptor complexesHomodimerizationReceptor–receptor interactionsReceptor tyrosine kinases (RTKs)

Identifiers

PMID24143976
PMCPMC3921556
OpenAlexW173323332

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.